Stock comparison

AMGNvsGILD

Amgen IncvsGilead Sciences Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

AMGN

Amgen Inc

$348.62

+6.70%

Biotechnology$188.8BNASDAQ

GILD

Gilead Sciences Inc

$133.64

+10.12%

Biotechnology$173.4BNASDAQ

60-day price, rebased to 100

AMGN +1.97% · GILD -6.47%

Round-by-round

AMGN 1·GILD 3· 2ties

EdgeGILD

Valuation upside

-41.60% vs -27.50% to DCF fair value

EdgeGILD

Balance-sheet strength

Altman Z 1.78 vs 4.47

Tie

Fundamental quality

Piotroski 8.00 vs 8.00 (of 9)

EdgeGILD

Growth + margins

Rule-of-40 32.00 vs 34.50

EdgeAMGN

60-day momentum

+1.97% vs -6.47% price return

Tie

Market-cap liquidity

$188.8B vs $173.4B

Verdict

Across6categories,GILDtakes the edge with3wins to1 (and 2 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onAMGNorGILD

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.